Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Meribel Pharma Karlskoga AB
AB
Active
Org 5566624366
Björkbornsvägen 5, 691 33
Karlskoga
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2004
164 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Meribel Pharma Karlskoga AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
119M
239M
358M
477M
340M
2020
355M
2021
385M
2022
377M
2023
415M
2024
EBITDA
SEK millions
0M
22M
43M
65M
86M
22M
2020
32M
2021
36M
2022
31M
2023
75M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
340 208
355 025
384 871
376 506
414 963
Staff expenses
—
—
—
—
—
EBITDA
21 835
32 156
36 159
31 097
74 659
Depreciation & amort.
−10 360
−11 555
−10 645
−10 976
−12 563
EBIT
11 475
20 601
25 514
20 121
62 096
Net financials
3 543
−8 489
−9 306
−11 918
−3 951
Profit before tax
22
−58
−3 187
−5 272
−237
Tax
−5
−0
−336
−0
−0
Net profit
17
−58
−3 523
−5 272
−237
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
208 950
238 737
214 437
229 204
306 226
Equity
6 234
4 115
591
319
125 082
Long-term debt
174
0
0
0
0
Short-term debt
193 798
226 429
213 846
228 885
181 144
Total debt
193 972
226 429
213 846
228 885
181 144
Financial ratios
5-year trend
EBITDA margin
18.0%
This company
15.8%
Market median
+14% vs market
2020
2024
Equity ratio
40.8%
This company
38.2%
Market median
+7% vs market
2020
2024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
2020
2024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
2020
2024
Asset turnover
1.36×
This company
1.12×
Market median
+21% vs market
2020
2024
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Meribel Pharma Karlskoga AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
